Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Resonance Health Ltd

RHT.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Advanced Medical Equipment & Technology ·

Australia Micro Cap Analyst: N/A

Last Close

$0.04

▲ +0.00%

Market Cap $17.84M · Vol 19.70K

Key Metrics

P/E Ratio

35.57

FWD: N/A

Market Cap

$17.84M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

51.61

Momentum

Beta

1.59

vs Market

52W High

$0.05

16.48% below

52W Low

$0.02

72.78% above

Volume

19.70K

Avg 340.69K

P/B

1.91

Price-to-book

ROE

N/A

Return on equity

Free Float

59.36%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Resonance Health Ltd (RHT.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does RHT.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-11.67%

+12.77%

+23.26%

YTD

+8.16%

+29.27%

-10.54%

-60.74%

Financials & Valuation

TTM · Annual

Total Revenue	$7.34M
Net Income	$-1,140,272.00
Revenue Growth (YoY)	+51.54%
Gross Margin	100.00%
Operating Margin	-16.49%
Net Profit Margin	-15.53%
ROE	N/A
ROA · ROIC	-11.52% · N/A

P/E Ratio	35.57
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.59
P/B	1.91
P/FCF	28.38
EPS Growth	N/A
Outstanding Shares	477.12M

Technical Indicators

50-Day SMA	$0.03
200-Day SMA	$0.03
RSI (14)	51.61
Beta	1.59
52-Week High	$0.05
52-Week Low	$0.02

Volume Today	19.70K
Avg Daily Volume (30D)	340.69K
Relative Volume	0.06x
Volatility (10D)	42.89
Volatility (30D)	72.59
Free Float	59.36%

Analyst Consensus

N/A

Current Price $0.04

Mean Target N/A

52W Low$0.02 52W High$0.05

Current

Target

$0.02 $0.05

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG001S8WN03

ISINAU000000RHT2

CountryAustralia

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

Resonance Health Limited is an Australia-based healthcare technology and services company. The Company is engaged in the development and commercialization of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its segments include software-as-medical-device (SaMD), Corporate, Resonance Clinical, and TrialsWest. Its SaMD products incorporate such as Artificial Intelligence (AI) FerriScan, FerriSmart, HepaFatScan, HepaFatSmar, LiverSmart, and CardiacT2. FerriScan is a core-lab product that provides an accurate assessment of liver iron concentration (LIC) through non-invasive MRI-based technology, for use in the assessment of individuals with iron overload conditions. It operates as the Clinical Trial Research Organisation (CRO) and local sponsor for a major global pharma company's clinical trial in Australia of a new drug compound.